Is JCO or JNJ a better dividend investment in 2026?

JCO currently yields 25.16% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: JCO offers higher current income.

What is the dividend yield difference between JCO and JNJ?

JCO has a forward dividend yield of 25.16% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 21.80 percentage points.

Home › Compare › JCO vs JNJ

JCO vs JNJ: Dividend Comparison 2026

JCO yields 25.16% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 JCO wins by $2.16M in total portfolio value

INVESTMENT

TIME HORIZON10 years

JCO

● Live price

25.16%

Share price

$7.95

Annual div

$2.00

5Y div CAGR

24.1%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2.18M

Annual income

$1,147,261.66

Full JCO calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — JCO vs JNJ

📍 JCO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	JCO	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, JCO + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

JCO pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JCO

Annual income on $10K today (after 15% tax)

$2,138.36/yr

After 10yr DRIP, annual income (after tax)

$975,172.41/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, JCO beats the other by $974,468.80/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JCO + JNJ for your $10,000?

JCO: 50%JNJ: 50%

100% JNJ50/50100% JCO

Portfolio after 10yr

$1.10M

Annual income

$574,044.72/yr

Blended yield

52.12%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

JCO

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JCO buys

JNJ buys

No recent congressional trades found for JCO or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricJCOJNJ

Forward yield	25.16% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	24.1% ✓	5.8%
Portfolio after 10y	$2.18M	$20.0K ✓
Annual income after 10y	$1,147,261.66 ✓	$827.78
Total dividends collected	$2.03M	$5.6K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: JCO vs JNJ ($10,000, DRIP)

Year	JCO Portfolio	JCO Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$13,822	$3,122.01	$10,676	$355.77	+$3.1K → JCO
2	$19,794	$5,004.88	$11,407	$389.39	+$8.4K → JCO
3	$29,493	$8,312.92	$12,198	$426.53	+$17.3K → JCO
4	$45,923	$14,365.38	$13,056	$467.62	+$32.9K → JCO
5	$75,080	$25,942.73	$13,987	$513.12	+$61.1K → JCO
6	$129,528	$49,192.63	$14,998	$563.56	+$114.5K → JCO
7	$237,025	$98,430.06	$16,098	$619.52	+$220.9K → JCO
8	$462,521	$208,903.50	$17,295	$681.69	+$445.2K → JCO
9	$967,689	$472,791.77	$18,599	$750.82	+$949.1K → JCO
10	$2,182,689	$1,147,261.66	$20,022	$827.78	+$2.16M → JCO

JCO vs JNJ: Complete Analysis 2026

JCO — Stock

Nuveen Credit Opportunities 2022 Target Term Fund is a closed ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors, LLC and Symphony Asset Management. It invests in fixed income markets of the United States. The fund primarily invests in corporate debt securities including bonds and senior loans. It invests in investment grade fixed income securities rated BBB- or higher by S&P with a maturity date on June 1, 2022. The fund employs a fundamental analysis with bottom-up stock picking approach while focusing on factors such as sector dynamics, company business models and asset quality and analysis of the relative value to create its portfolio. Nuveen Credit Opportunities 2022 Target Term Fund was formed on September 28, 2016 and is domiciled in the United States.

Full JCO Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this JCO vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JCO vs SCHD JCO vs JEPI JCO vs O JCO vs KO JCO vs MAIN JCO vs ABBV JCO vs MRK JCO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.